alz-pharma.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot / ✔
BingBot / ✔
BaiduSpider / ✔
YandexBot / ✔ 
User-agent: * Disallow: /cart Disallow: /wishlist Disallow: /checkout Disallow: /my-account Disallow: /*?orderby* Disallow: /*?filter Disallow: /*add-to-cart=* Disallow: /*?add_do_wishlist=* Allow: /wp-admin/admin-ajax.php Crawl-delay: 10 User-agent: PetalBot Disallow: / User-agent: SemrushBot Disallow: / User-agent: AhrefsBot Disallow: / Sitemap:
Meta Tags
Title Amolyt Pharma - Advancing peptides for the treatment of rare endocrine and metabolic
Description Advancing peptides for the treatment of rare endocrine and related We are building on our team’s established expertise in therapeutic peptides to deliver life-changing treatments to patients suffering from rare endocrine and metabolic
Keywords N/A
Server Information
WebSite alz-pharma faviconalz-pharma.com
Host IP 164.90.176.158
Location United States
Related Websites
Site Rank
More to Explore
westcoastwheelandtire.com
dv8motoring.com
funhomebroadway.com
ofwa.ca
mrfa.net
navygreatlakesfamilyhousing.com
icso-hw.org
seancoyne.org
naot.com.au
sheratononthefalls.com
stanleybusinessdaily.com
oreganskia.com
niagarafallsmarriott.com
orcaseakayaking.com
flyfishvancouver.com
stubbs-island.com
oreganshyundaibridgewater.com
paylessmedical.com
pchealthdesk.com.au
pittriverlodge.com
alz-pharma.com Valuation
US$1,365
Last updated: 2023-05-12 19:18:19

alz-pharma.com has Semrush global rank of 0. alz-pharma.com has an estimated worth of US$ 1,365, based on its estimated Ads revenue. alz-pharma.com receives approximately 157 unique visitors each day. Its web server is located in United States, with IP address 164.90.176.158. According to SiteAdvisor, alz-pharma.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$1,365
Daily Ads Revenue US$1
Monthly Ads Revenue US$37
Yearly Ads Revenue US$453
Daily Unique Visitors 10
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
alz-pharma.com. A 3599 IP: 164.90.176.158
alz-pharma.com. NS 86400 NS Record: ns3.bdm.microsoftonline.com.
alz-pharma.com. NS 86400 NS Record: ns4.bdm.microsoftonline.com.
alz-pharma.com. NS 86400 NS Record: ns1.bdm.microsoftonline.com.
alz-pharma.com. NS 86400 NS Record: ns2.bdm.microsoftonline.com.
alz-pharma.com. MX 3600 MX Record: 0 alzpharma-com0i.mail.protection.outlook.com.
alz-pharma.com. TXT 3600 TXT Record: mscid=PgBqG8vbF2Nei4k0/Ct1eXpba/kd7ALIe+xm0Pv4xtzAfAJ8c6ancTUZTHq5HucGl0l8KGX/86MiYphnl25ahw==
alz-pharma.com. TXT 3600 TXT Record: v=spf1 include:spf.protection.outlook.com -all
HtmlToTextCheckTime:2023-05-12 19:18:19
Main Menu ABOUT US PROGRAMS Pipeline Eneboparatide: Hypoparathyroidism​ AZP-3813: Acromegaly PATIENTS NEWS CAREERS CONTACT US World Hypopara Awareness Day is June 1! Join us in raising awareness for people living with hypoparathyroidism and share this link . Amolyt Pharma Announces Oral Presentation at the 25 th European Congress of Endocrinology (ECE) 2023 May 11, 2023 Download a PDF: EN or  FR Advancing peptides for the treatment of rare endocrine and related diseases We are a clinical stage, global company, building on our team’s established expertise to transform the lives of patients living with rare endocrine and related diseases. PROGRAMS Eneboparatide Our lead clinical candidate is a potentially clinically superior therapeutic peptide in development for hypoparathyroidism. Learn more about eneboparatide » Eneboparatide (red) bound to the PTH1 receptor. Adapted from Zhao et al. Science 364:138, 2019. Image generated with the PyMOL Molecular Graphics System, Version 2.3.2
HTTP Headers
HTTP/1.1 301 Moved Permanently
Server: nginx
Date: Sun, 19 Dec 2021 20:49:52 GMT
Content-Type: text/html
Content-Length: 162
Connection: keep-alive
Location: https://alz-pharma.com/

HTTP/2 301 
server: nginx
date: Sun, 19 Dec 2021 20:49:52 GMT
content-type: text/html; charset=UTF-8
location: https://amolytpharma.com/
x-redirect-by: WordPress
x-cache: MISS

HTTP/2 200 
server: nginx
date: Sun, 19 Dec 2021 20:49:53 GMT
content-type: text/html; charset=UTF-8
vary: Accept-Encoding
x-pingback: https://amolytpharma.com/xmlrpc.php
link: ; rel="https://api.w.org/"
link: ; rel="alternate"; type="application/json"
link: ; rel=shortlink
x-cache: HIT
alz-pharma.com Whois Information
Domain Name: ALZ-PHARMA.COM
Registry Domain ID: 935258318_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.networksolutions.com
Registrar URL: http://networksolutions.com
Updated Date: 2021-04-18T05:16:55Z
Creation Date: 2007-04-20T15:12:08Z
Registry Expiry Date: 2022-04-20T15:12:08Z
Registrar: Network Solutions, LLC
Registrar IANA ID: 2
Registrar Abuse Contact Email: abuse@web.com
Registrar Abuse Contact Phone: +1.8003337680
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS1.BDM.MICROSOFTONLINE.COM
Name Server: NS2.BDM.MICROSOFTONLINE.COM
DNSSEC: unsigned
>>> Last update of whois database: 2021-12-23T07:27:59Z <<<

Copyright © 2022 WebZZ.US 2.0333